Utilization of dietary vitamin K supplementation to aid in INR stabilization for patients on chronic oral anticoagulant therapy: a series of case reports

被引：1

作者：

Earl, L. ^{[1
]}

Pena, R. ^{[2
]}

Hutchinson, J. ^{[3
]}

机构：

[1] Univ New Mexico Hosp, Albuquerque, NM USA

[2] Lovelace Healthcare Syst, Albuquerque, NM USA

[3] Holy Cross Hosp, Taos, NM USA

来源：

JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2008年 / 25卷 / 01期

关键词：

D O I：

10.1007/s11239-007-0112-y

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：91 / 91

页数：1

共 50 条

[31] Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients
Hodkova, M
Dusilova-Sulkova, S
Skalicka, A
Kalousova, M
Zima, T
Bartunkova, J
RENAL FAILURE, 2005, 27 (02) : 135 - 141
[32] More monitoring: Non-vitamin K-dependent oral anticoagulant agent use in chronic kidney disease patients
Khoury, Charbel C.
Chan, Kevin E.
AMERICAN HEART JOURNAL, 2017, 184
[33] DOES ANTIPLATELET THERAPY INCREASE THE BLEEDING EVENTS AMONG PATIENTS WITH NON VITAMIN K ANTAGONIST ORAL ANTICOAGULANT IN REAL WORLD?
Okamoto, Yoji
Fujii, Satoki
Ozaki, Masatomo
Yoshino, Mitsuru
Ohashi, Noriyuki
Tasaka, Hiroshi
Kadota, Kazushige
Mitsudo, Kazuaki
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A351 - A351
[34] (Absence of) Association Between Non-Vitamin K Antagonist Oral Anticoagulant Therapy and Urinary Tract Infection in Patients With Atrial Fibrillation
Heidemann, Jana
Tanislav, Christian
Kostev, Karel
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (06) : 830 - 834
[35] Oral Anticoagulant Therapy in Patients with Philadelphia-Negative Myeloproliferative Neoplasms: A Real-Life Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
Cavalca, Fabrizio
Civettini, Ivan
Bonfanti, Stefano
Gambacorti-Passerini, Carlo
Elli, Elena Maria
BLOOD, 2023, 142
[36] Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists Replacement of Annex 3 of WHO Technical Report Series, No. 889
WHO EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION, SIXTY-SECOND REPORT, 2013, 979 : 271 - 316
[37] Bleeding risk in patients with atrial fibrillation treated with combined anti-platelet and non-vitamin K antagonist oral anticoagulant therapy
Shin, Dong Geum
Kim, Sunhwa
Kim, Yoo Ri
REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (01)
[38] Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
Nijole Bernaitis
Tony Badrick
Shailendra Anoopkumar-Dukie
Journal of Thrombosis and Thrombolysis, 2021, 52 : 1110 - 1116
[39] Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
Bernaitis, Nijole
Badrick, Tony
Anoopkumar-Dukie, Shailendra
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (04) : 1110 - 1116
[40] UTILIZATION PATTERNS OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION WHO FAILED WARFARIN THERAPY
Han, S.
Jeong, H. S.
Kim, H. T.
Suh, H. S.
VALUE IN HEALTH, 2017, 20 (05) : A277 - A277

← 1 2 3 4 5 →